A Pseudovirus Nanoparticle-Based Trivalent Rotavirus Vaccine Candidate Elicits High and Cross P Type Immune Response
Rotavirus infection continues to cause significant morbidity and mortality globally. In this study, we further developed the S<sub>60</sub>-VP8* pseudovirus nanoparticles (PVNPs) displaying the glycan receptor binding VP8* domains of rotavirus spike proteins as a parenteral vaccine candi...
Main Authors: | Ming Xia, Pengwei Huang, Ming Tan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/8/1597 |
Similar Items
-
A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses
by: Ming Xia, et al.
Published: (2021-01-01) -
Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help?
by: Jacqueline Deen, et al.
Published: (2018-02-01) -
Milk lactose protects against porcine group A rotavirus infection
by: Xiaolei Ren, et al.
Published: (2022-08-01) -
Monitoring the circulation of rotavirus among children after the introduction of the RotarixTM vaccine in Goiânia, Brazil
by: Ana Maria Tavares Borges, et al.
Published: (2011-06-01) -
Evolution of P[8], P[4], and P[6] VP8* genes of human rotaviruses globally reported during 1974 and 2017: possible implications for rotavirus vaccines in development
by: Daniel E. Velasquez, et al.
Published: (2019-12-01)